CareDx Inc., a California-based healthcare company, has announced a suite of innovative diagnostic solutions for transplant patients and caregivers. The company's offerings include AlloSure Kidney, AlloMap Heart, AlloSure Heart, and AlloSure Lung - all of which provide donor-derived cell-free DNA (dd-cfDNA) solutions for transplant patients. CareDx also provides Olerup SSP, QTYPE, Ottr, AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, and XynQAPI - all of which offer high-resolution HLA typing solutions and transplant patient management software. The company also offers its products directly to customers or through third-party distributors and sub-distributors. Moreover, CareDx has a licensing agreement with Illumina Inc., which allows the distribution, development, and commercialization of NGS products and technologies.
CareDx's ticker is CDNA
The company's shares trade on the NASDAQ stock exchange
They are based in South San Francisco, California
There are 501-1000 employees working at CareDx
It is caredx.com
CareDx is in the Healthcare sector
CareDx is in the Diagnostic Substances industry
The following five companies are CareDx's industry peers: